Moderna, Inc. MRNA

Atualmente 2 altistas, 1 baixistas — cada vez mais polarizado.

Os analistas se mantêm estáveis em 2 altistas para 1 baixistas.

3 analistas do YouTube cobrem Moderna, Inc. (MRNA).

3 analistas cobriram MRNA até agora…

Opiniões dos analistas

StockCharts TV7d ago

BULL$MRNACurtoTécnico

rompimento acima de $58 até $62 sinaliza reversão.

A MRNA rompeu a resistência anterior perto de $58, fechando quase em $62, com um padrão de fundo duplo e volume forte sinalizando uma possível mudança de tendência.

Após formar um fundo duplo, a MRNA sustentou o suporte e rompeu hoje, fechando perto de $62 e superando as máximas anteriores em torno de $58. Esse movimento técnico, especialmente se o fluxo de capital migrar para setores defensivos, sustenta um cenário otimista.

"This Market Rally Faces A Big Test"

Jack Corsellis43d ago

BULL$MRNACurtoTécnico

Bullish on $MRNA: ORB works in flush/EMA contexts — avoided when the setup is near “extended/no-no” index conditions.

MRNA can fit the ORB framework when the indexes are flushing and the stock is near key daily moving averages, because the “no-no” zones are described as occurring when the index is extended the other way.

MRNA is framed as a tradable ORB candidate specifically when the index action lines up with mean-reversion and snapback behavior around daily moving averages. The risk note is contextual: the approach warns against taking the same type of setups when the index tape is in the unfavorable “no-no” state.

"The Trading Session That Nearly Ruined My Month (+17% Recovery)"

Valuetainment48d ago

BEAR$MRNA

next-gen shot framed as ongoing pathogen risk signal

MRNA appears to be preparing next-generation mRNA shots related to this “antivirus” threat (citing work from 2024 with Korea University), which he frames as evidence the vaccine program is implicitly tied to ongoing pathogen risk.

Next-generation mRNA vaccine development tied to 2024 research with Korea University is framed as implicit evidence that the vaccine program is linked to continuing pathogen risk rather than a standalone commercial opportunity.

""Mass Negligent Homicide" - Hantavirus Outbreak Surges As Fauci Deadline Nears"

Ainda não surgiram registros oficiais para MRNA.